ArticleJournal of sleep research2025
Actigraphy against 32-hour polysomnography in patients with suspected idiopathic hypersomnia.
Article in Journal of sleep research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Actigraphy-based sleep outcomes in substance use disorders: A protocol for a systematic review and meta-analysis.PloS one · 2026Article
- Idiopathic hypersomnia is a 24-hour disorder.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2025Review
- Actigraphy against 32-hour polysomnography in patients with suspected idiopathic hypersomnia.Journal of sleep research · 2025Article
- WACSAW: An adaptive, statistical method to classify movement into sleep and wakefulness states.PloS one · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Actigraphy, a tool known for investigating sleep-wake patterns at home, lacks scientific validation in hypersomnolent subjects. We aim to validate an actigraphy-based sleep-wake prediction algorithm against 32-h continuous polysomnography in patients with suspected idiopathic hypersomnia, and to compare its performance to predict sleep-wake parameters assessed by polysomnography with those of a commercially available algorithm. Two hundred and six hypersomnolent subjects were included prospectively in a Reference Centre for Hypersomnias, and underwent a 32-h bedrest protocol, wearing wrist-actigraphy, to diagnose idiopathic hypersomnia. Among them, 126 patients (91 females, 30.6 ± 15.5 years, 101 idiopathic hypersomnia, 25 non-specified hypersomnia) with synchronised actigraphy and polysomnography were analysed. Age, sex, and Epworth Sleepiness Scale scores were collected. We trained various supervised algorithms and selected a recurrent neural network (S2S sequence-to-sequence long short-term memory network) for comparison with Actiwatch Software (AS) on sleep-wake variables and prediction errors during daytime and nighttime. S2S outperformed AS across all relevant metrics, and Bland-Altman analysis showed disagreement between the two algorithms. S2S had a lower absolute error than AS. AS mainly overestimated sleep, an overestimation that was substantially reduced with S2S, overall as well as during day and night. Performance was not correlated with age, sex, or subjective sleepiness, but objective sleepiness and longer sleep time on the bedrest were associated with sleep underestimation. Our S2S algorithm using deep learning performed better to predict sleep-wake parameters than AS and other commonly used algorithms. The next objective is to leverage this algorithm to study sleep-wake patterns in patients with hypersomnolence at home.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.